🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Every day I read about a bright academician leaving academia to join industry & while I am sure the moves have good personal reasons, they are disheartening for the field. The field is seeing less & less independent clinical trial work in a rapidly changing academic environment..

I always do one non-asco thing each #asco. I have seen a lot of Chicago Cubs games but tonight, I couldn’t pass up SIX 👑 with mom.

Excited to share our team's publication within the Journal of Urology, where we investigated patient satisfaction with clinician-led genetic counseling. Thank you to my co-first-author, Marissa A. Solorzano, and mentor, Todd 〽️ Morgan, MD. auajournals.org/doi/10.1097/JU… Journal of Urology Amer. Urol. Assn.

Great collab evaluating hypothesis that ctDNA tumor fraction may be prognostic across cancers. Full 🧵to follow! What a team! Z Reichert Todd 〽️ Morgan, MD U-M Rogel Cancer Center, E. Castellanos et al Flatiron Health, Geoff Oxnard MD Ryon Graf, PhD Foundation Medicine The James h/t Paolo Tarantino!

This article in Annals of Oncology reports on the prognostic value of ctDNA fraction across different tumor types using real-world data from a de-identified clinico-genomic database annalsofoncology.org/article/S0923-… Ryon Graf, PhD Zachery Reichert, MD, PhD Geoff Oxnard MD Todd 〽️ Morgan, MD Daniel Stover, MD, FASCO

We're recruiting an Assistant Prof to join our GU Med Onc Team U-M Rogel Cancer Center! Clinical trials focus is preferred. University of Michigan is highly collaborative with many GU team science initiatives & multi-D care. Apply: medicine.umich.edu/dept/intmed/di… or email me. Please RT! PCF Science The PCCTC

We are recruiting an Assistant Prof to join our Sarcoma Med Onc Team U-M Rogel Cancer Center! Clinical trials focus is preferred. University of Michigan is highly collaborative with multi-D care and team science including a new SPORE. Please apply at medicine.umich.edu/dept/intmed/di…. Rashmi Chugh Christina Angeles MD

Thanks 09G rouge Detroit City FC Youth West for supporting teammate Brynn at her basketball game for All-Saints Athletics. Go Blue Thunder, Go City!

APEX-01: First-in-human Ph 1/2 study of ARX517, an anti-PSMA ADC, in mCRPC #ESMO23 UroToday.com 🚩n=65, median 4 prior LoT 🚩Gr 1/2 TRAEs: dry mouth (28%), fatigue (20%), diarrhea (15%) 🚩52%: ≥50% PSA ⬇️ at therapeutic doses ≥ 2.0 mg/kg 🚩⬇️≥ 50% in ctDNA: 81% cohorts 6-8

Mom still coming through in amazing ways: You should be fine for a while,” he said helpfully. “But I wouldn’t plan that trip in a few years to France.” “How about Italy?” I asked. seattlemag.com/love-and-wisdo… Seattle magazine

Straight from #ASCO24 to Wrigley field for Chicago Cubs vs Cincinnati Reds. Go Cubs! Just need Todd 〽️ Morgan, MD and more home runs to keep dad in the game from prostate cancer Prostate Cancer Foundation

Had a fun time presenting our poster at #ASCO2024 on #ctDNA in pts with #mHSPC! Thanks to our pts, mentor Zachery Reichert, MD, PhD, and Todd 〽️ Morgan, MD lab as well as Foundation Medicine for the collaboration! Lincoln Pasquina Ryon Graf, PhD GU Oncology Now Uromigos UroToday.com U-M Rogel Cancer Center

🚨 New pub: real-world PARP-I response in mCRPC according to DDR alteration status. Huge credit to 💫 Michigan Urology chief resident (and future Stanford Urology YUO fellow) Daniel A. Triner MD PhD and the amazing Ryon Graf, PhD for all their work on this.

Proud to see our very own UMich Rad Onc Will Jackson Will Jackson visiting Stanford Radiation Oncology as the McCollum @mybluedots visiting professor! Already a strong Michigan connection only getting stronger!

Germline genetic testing can reveal variants that may carry implications for patients with PCa. Most prevalent variants in 505 patients with PCa: CHEK2 (34%), BRCA2 (22%), ATM (10%), and HOXB13 (10%)🧬Zachery Reichert, MD, PhD Todd 〽️ Morgan, MD Marissa A. Solorzano auajournals.org/doi/10.1097/UP…

Thank you for having me! Had a great time discussing #nonclearcellRCC and current data. Sumanta K. Pal, MD, FASCO

ANNOUNCEMENT: RFA for 2025 Prostate Cancer Foundation Young Investigator Award Applications, to support innovative & highly promising early career #ProstateCancer researchers. DEADLINE: March 10, 2025 Apply at: pcf.smartsimple.com View the RFA here: res.cloudinary.com/pcf/images/v17…

One of best parts of RadOnc is the collaborative team work moving the field forward. The power of physician-physicist partnerships can’t be understated. & while you don’t have to marry them for it to work, Robert Dess Kathryn Masi Dess Alex Price & I think it’s a solid method 🤣

Excellent overview by Charles Nguyen City of Hope summarizing work he did with Todd 〽️ Morgan, MD Michigan Urology looking at ctDNA in mHSPC (publication pending). Charles is building a terrific program at City of Hope | Orange County focused on #prostatecancer & #kidneycancer - here he is

So proud to celebrate Daniel Wahl as the inaugural Achtenberg Family Research Professor of Rad Onc at Michigan Medicine! Beautiful event with a truly heartfelt and inspirational talk from Dr. Wahl. Sincere gratitude to Jim and Connie Achtenberg for their generosity. UMich Rad Onc